Stock Alert: Fulgent Up 12% On Getting EUA For Its Covid-19 Testing

Shares of Fulgent Genetics, Inc. (FLGT) are surging more than 12% Monday morning after the company announced that Fulgent Therapeutics, LLC, a unit of Fulgent Genetics received Emergency Use Authorization (EUA) from the FDA for its RT-PCR test for the detection of SARS-CoV-2 virus that causes Covid-19.

Fulgent stock is currently trading at $18.57, close to its 52 week high of 20.60.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Pharma Stocks by Subscribing to RTT Biotech Investor.
Editors Pick
The Federal Trade Commission or FTC, has sued Walmart for allowing its money transfer services to be used by fraudsters, who fleeced consumers out of hundreds of millions of dollars. The retail giant is alleged to have looked the other way to pocket millions in fees while scammers took advantage of its failure to properly secure the money transfer services offered at Walmart stores. Home improvement retailer Bed Bath & Beyond, Inc. (BBBY) reported on Wednesday a net loss for first quarter that sharply widened from last year, hurt by hefty transient costs related to inventory markdown reserves and port-related supply chain fees. Both adjusted loss per share and net sales missed analysts' expectations. Tesla Inc. laid off about 200 employees in its Autopilot unit as the luxury electric car maker closed down its office in San Mateo, California as part of cost cutting efforts, reports said. The San Mateo office, where employees worked on improving the driver assistance systems, marketed as Autopilot, had about 350 employees before the cut.
Follow RTT